Abstract:Objective: To determine the level of cellular oxidative stress blood markers and the enzymatic system of antioxidant defense establishing the oxidative profile in patients with Juvenile Rheumatoid Arthritis.Methods: Case-control study that included 64 patients (46 of female sex) with Juvenile Rheumatoid Arthritis (JRA) following clinical control in the Pediatric Rheumatology Service of the Vall d'Hebron Hospital, Barcelona, Spain. The patients were separated in three subtypes based on the pattern of onset with… Show more
“…Ramos et al (2000) found that OxS markers such as plasma levels of hydroperoxide and malon dialdehyde were significantly higher in patients with JRA when compared with the controls, especially in the systemic sybgroup, which is considered to be the most severe form of the disease [5]. Renke et al (2007) found an increased level of plasma protein carbonyls at diagnosis and after a year of treatment in JIA patients as compared to controls.…”
Section: Discussionmentioning
confidence: 99%
“…HOCl belongs to reactive oxygen species (ROS). Cells that are present in infla med joints (macrophages, neutrophils, lymphocytes, and endothelial cells) are capable of producing ROS, which damage the articular cartilage [5]. Plasma MPO levels are accepted as a new marker for both inflammation and oxidative stress (OxS), whereas both condi tions have an impact on vascular dysfunc tiona lities [6].…”
Section: Introductionmentioning
confidence: 99%
“…So far there are very few studies on the role of OxS in JIA. JIA patients present high concentrations of lipid peroxidation products, oxida tive damage of proteins, changes in activity of antioxidative enzymes, decreased anti oxidative glutathione levels and enhanced nit rite/nitrate produ ction in the joints [5,11]. As the etiopathology of JIA varies between the subtypes, the role of MPO in different JIA subtypes may also be different.…”
AbstractTo examine the plasma levels of MPO in oligoarthritis and polyarthritis subtypes of JIA in comparison with healthy age-matched controls. Thirty-eight JIA patients (25 girls and 13 boys) aged 9.1–11.8 years and 23 healthy controls (8 girls and 15 boys) participated in the study. Twenty-one patients had oligoarthritis (8 with extended oligoarthritis) and 17 had polyarthritis (among them three were seropositive). The plasma concentration of MPO was measured by the ELISA technique (OxisResearchTM, BIOXYTECH® MPO-EIATM, Portland, OR USA). The mean plasma concentration of MPO in the JIA group was significantly higher than in the control group (76.6±24.8 µg/L versus 62.7±15.6 µg/L; p=0.01). Patients with polyarthritis presented a significantly higher mean plasma MPO level than patients with oligoarthritis (81.3±25.6 µg/L and 62.1±27.1 µg/L, respectively; p=0.02). Different subtypes of JIA may have different MPO-related backgrounds. MPO is a new potent inflammatory marker. Patients with polyarthritis have higher mean plasma MPO levels than patients with oligoarthritis and may therefore have an enhanced risk for subclinical oxidative stress-related atherogenic promotion.
“…Ramos et al (2000) found that OxS markers such as plasma levels of hydroperoxide and malon dialdehyde were significantly higher in patients with JRA when compared with the controls, especially in the systemic sybgroup, which is considered to be the most severe form of the disease [5]. Renke et al (2007) found an increased level of plasma protein carbonyls at diagnosis and after a year of treatment in JIA patients as compared to controls.…”
Section: Discussionmentioning
confidence: 99%
“…HOCl belongs to reactive oxygen species (ROS). Cells that are present in infla med joints (macrophages, neutrophils, lymphocytes, and endothelial cells) are capable of producing ROS, which damage the articular cartilage [5]. Plasma MPO levels are accepted as a new marker for both inflammation and oxidative stress (OxS), whereas both condi tions have an impact on vascular dysfunc tiona lities [6].…”
Section: Introductionmentioning
confidence: 99%
“…So far there are very few studies on the role of OxS in JIA. JIA patients present high concentrations of lipid peroxidation products, oxida tive damage of proteins, changes in activity of antioxidative enzymes, decreased anti oxidative glutathione levels and enhanced nit rite/nitrate produ ction in the joints [5,11]. As the etiopathology of JIA varies between the subtypes, the role of MPO in different JIA subtypes may also be different.…”
AbstractTo examine the plasma levels of MPO in oligoarthritis and polyarthritis subtypes of JIA in comparison with healthy age-matched controls. Thirty-eight JIA patients (25 girls and 13 boys) aged 9.1–11.8 years and 23 healthy controls (8 girls and 15 boys) participated in the study. Twenty-one patients had oligoarthritis (8 with extended oligoarthritis) and 17 had polyarthritis (among them three were seropositive). The plasma concentration of MPO was measured by the ELISA technique (OxisResearchTM, BIOXYTECH® MPO-EIATM, Portland, OR USA). The mean plasma concentration of MPO in the JIA group was significantly higher than in the control group (76.6±24.8 µg/L versus 62.7±15.6 µg/L; p=0.01). Patients with polyarthritis presented a significantly higher mean plasma MPO level than patients with oligoarthritis (81.3±25.6 µg/L and 62.1±27.1 µg/L, respectively; p=0.02). Different subtypes of JIA may have different MPO-related backgrounds. MPO is a new potent inflammatory marker. Patients with polyarthritis have higher mean plasma MPO levels than patients with oligoarthritis and may therefore have an enhanced risk for subclinical oxidative stress-related atherogenic promotion.
“…Rheumatoid arthritis is a chronic relapsing immunoinflammatory multisystem disease with predominant synovial proliferation and destruction of the articular cartilage and bone (28) (21). It has been shown that, especially in RA, monocytes produce 2.7 times more oxygen radicals than controls (22).…”
Section: Discussionmentioning
confidence: 99%
“…These systems consist of nonenzymatic antioxidants-including nonprotein antioxidants with low molecular weights (vitamins A and E, beta-carotene, uric acid) and of enzymes such as SOD, catalase, glutathione peroxidase, and glutathione reductase. The activity of SOD, a catalyst for dismutation of superoxide radicals into H 2 O 2 and into molecular oxygen, protects cell and tissues from superoxide radicals and other peroxides (28). In several studies, lower activity of SOD (29) and no change in SOD (30) were shown.…”
ÖzetAmaç: Son yıllarda romatoid artrit (RA) gibi inflamatuvar artritlerin patogenezinde reaktif oksijen metabolitlerinin rolüne ilgi oldukça artmıştır. Bizim bu çalışmamızdaki amaçlarımız RA hastalarında plazma ve özellikle eritrositlerdeki oksidan ve antioksidan statüyü araştırmak ve bu statünün hastalık aktivite indeksi (DAS) 28'e göre ılımlı, orta ve şiddetli olarak ayrılan hastalık aktivitesi ile ilişkisini belirlemektir. Yöntem ve Gereçler: Elli RA hastası ve 26 kontrolden alınan açlık kan örneklerinde plazmada ve eritrosit içinde malondialdehit (MDA), ksantin oksidaz (XO), ve superoksit dismutaz (SOD) değer-lerine bakıldı. Hastalık aktivitesinin değerlendirilmesinde ise Hastalık Aktivite Skoru (DAS)-28 kullanıldı. Bulgular: Romatoid artrit hastalarında MDA ve XO'nun plazma seviyeleri ile MDA ve SOD'nin eritrosit seviyeleri kontrol grubundan anlamlı derecede fazla idi. Her ne kadar MDA'nın plazma seviyeleri ılımlı ve orta, eritrosit seviyeleri ise ılımlı aktivite grubunda kontrollerden farklı değilse de (p>0.05) plazma seviyeleri şiddetli (p=0.001), eritrosit seviyeleri hem orta (p<0.001) hem de şiddetli RA hastalarında (p<0.001) anlamlı olarak yüksekti. RA hastalarında plazma SOD seviyeleri anlamlı yükseklik göstermese de (p=0.241) eritrosit SOD seviyelerinde anlamlı bir artış vardı (p<0,001). Eritrosit SOD aktivitesindeki bu artış ılımlı RA'da anlamlı olmasa da orta ve şiddetli RA'da oldukça anlamlıydı (sıra-sıyla p=0.002 and p<0.001). Sonuç: Çalışmamızda bulduğumuz sonuçlar özellikle şiddetli hastalık aktivitesi bulunan RA hastalarında artan plazma ve eritrosit MDA seviyelerinin inflamasyona bağlı olarak oksidatif stresi artır-dığını göstermektedir. Bununla birlikte özellikle orta ve şiddetli aktivitesi olan RA hastalarındaki eritrosit SOD aktivitesindeki artış ile bu strese en azından hücresel seviyede karşı koymaya çalışıldığını öne sürebiliriz. (Turk J Rheumatol 2010; 25: 141-6)
CD5L, ITGβ5, M2BP, MPO, MMP-3, and CRP level are markers for PsA. The combination of ITGβ5, M2BP, and CRP level differentiates PsA from PsC, and performs better than CRP level alone.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.